Brief: Annexin Pharmaceuticals Rights Issue Oversubscribed
Feb 26 (Reuters) - Annexin Pharmaceuticals AB (publ)
ANNX.ST :
* ANNEXIN PHARMACEUTICALS AB (PUBL) - RIGHTS ISSUE
OVERSUBSCRIBED
* ANNEXIN PHARMACEUTICALS AB (PUBL) - GETS PROCEEDS OF ABOUT
SEK
61 MILLION BEFORE ISSUE COSTS
Source text for Eikon: ID:nWkr73ZTd8
Further company coverage: ANNX.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Annexin Pharmaceuticals AB (publ)
See all newsBrief: Annexin Pharmaceuticals Q3 Net Loss At SEK 9.5 Mln
Brief: Annexin Pharmaceuticals Q2 2026 Net Loss SEK 11.6 Mln
Brief: Annexin Pharmaceuticals Gets International Nonproprietary Name Drug Candidate Anxv
Brief: Annexin Pharmaceuticals Updates On Nine Patients Treated In Nexus Study
Brief: Annexin's Rights Issue 98% Subscribed